Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation.
Impact in
- Immunology 531
- Epidemiology 192
Classified as
- Journal
- PubMed
In The Last Decade
doi.org/w2293439 →Countries where authors are citing Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation.
This map shows the geographic impact of Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. more than expected).
Fields of papers citing Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation.
This network shows the impact of Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation..
About Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation.
This paper, published in 2002, received 692 indexed citations . Written by Kristina Edfeldt, Jesper Swedenborg, Göran K. Hansson and Zhong-qun Yan covering the research area of Immunology. It is primarily cited by scholars working on Immunology (531 citations), Epidemiology (192 citations), Molecular Biology (188 citations), Surgery (69 citations) and Cancer Research (66 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w2293439.